• Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +4

  • Study on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults

    Recruiting

    2 1
    Investigated diseases:
    Czechia Germany The Netherlands Poland Spain

  • Study on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Effectiveness of Lidocaine Hydrochloride and Sodium Chloride for Treating Headaches in Patients with Spontaneous Brain Bleeding

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Safety and Effects of MK-3120 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated drugs:
    France The Netherlands Poland Spain

  • Study on Isoflurane, Propofol, and Dobutamine Hydrochloride for Sedation in Adults with Severe Cardiogenic Shock on ECMO

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Adding Darolutamide to First-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Denmark Hungary Italy The Netherlands Poland Portugal

  • Study on Using Fluoroestradiol F-18 PET/CT for Detecting Endometriosis in Patients with Pain

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by